MedTrace Logo

The Effect of Alternate Nasal Breathing Exercise ın Hypertension

NCT07114952 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2025-08-11

No results posted yet for this study

Summary

This study is a randomized controlled experimental trial designed to examine the effect of alternative nasal breathing exercises on blood pressure and perceived stress levels in patients with hypertension. The study sample includes a total of 52 patients, with 26 in the intervention group and 26 in the control group.

Conditions

  • Hypertension (HTN)

Interventions

BEHAVIORAL

alternative nasal breathing

The alternate nasal breathing exercise involves breathing in and out through both nostrils in a certain pattern and for a certain period of time. For example, an individual who breathes in through the right nostril for 5 seconds with the left nostril closed, then closes the right nostril and exhales through the left nostril for 5 seconds. Then he/she inhales through the left nostril for 5 seconds and exhales through the right nostril. A total of 6 breaths are taken per minute. The application is applied for 5 minutes, the patient rests in a calm environment for two minutes and the application is performed for another 5 minutes. In order to increase the compliance of individuals with the application, a sample video was watched and application instructions were given by the researcher. The application was performed while the patients were in an upright sitting position.

Sponsors & Collaborators

  • Cukurova University

    collaborator OTHER

  • Adiyaman University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-06
Primary Completion
2025-05-26
Completion
2025-05-26

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07114952 on ClinicalTrials.gov